Full-text search

Results for “Tropic of Cancer”

Search across the indexed text of every released document.

168 documents found

James Niedel, MD, Ph.D., (70), Venture Partner, joined Sprout in May 2002 and helped found
document IMAGES-007-HOUSE_OVERSIGHT_024024.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

James Niedel, MD, Ph.D., (70), Venture Partner, joined Sprout in May 2002 and helped found New Leaf in 2005. Jim will change his status to Venture Partner in NLV-II] with the closing of the new fund. In this role, Jim will work full-time as a senior member of the NLV investment t...

Fwd: Invite to Dialog 2014 (16 months away)
email TEXT-001-HOUSE_OVERSIGHT_013484.txt Nov 28, 2012 House Oversight Committee — Epstein Estate Records (Nov 2025)

From: Ian Osborne Sent: 11/28/2012 5:55:14 PM To: Jeffrey Epstein [[email protected]] Subject: Fwd: Invite to Dialog 2014 (16 months away) Importance: High Same shit. Peter doesn't even attend. I will tell him that he should stop them using his name. Begin forwarded message:...

David Brooks (born August 11, 1961) is a political and cultural
document IMAGES-004-HOUSE_OVERSIGHT_017534.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

DAVID BROOKS David Brooks (born August 11, 1961) is a political and cultural commentator who writes for The New York Times. He worked as an editorial writer and film reviewer for the Washington Times; a reporter and later op-ed editor for The Wall Street Journal; a senior edito...

2014 at a groundbreaking ceremony in Summit, N.J., for Celgene, the pharmaceutical
document IMAGES-009-HOUSE_OVERSIGHT_028415.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

2014 at a groundbreaking ceremony in Summit, N.J., for Celgene, the pharmaceutical company he led until stepping down to run for United States Senate. To his right are Representative Leonard Lance of New Jersey and former Gov. Chris Christie. Mel Evans/Associated Press"},"identi...

sorry | missed your call
email IMAGES-010-HOUSE_OVERSIGHT_030430.txt Feb 6, 2017 House Oversight Committee — Epstein Estate Records (Nov 2025)

From: John Brockman Sent: 2/6/2017 8:34:19 PM To: Jeffrey Epstein [[email protected]] Subject: sorry | missed your call Importance: — High JE, --Last week was misery...On Tuesday, Katinka's' younger brother, Jonathan Matson, was planning on flying in from Boston and havin...

11/28/2012 5:28:55 PM
email TEXT-001-HOUSE_OVERSIGHT_017581.txt Nov 28, 2012 House Oversight Committee — Epstein Estate Records (Nov 2025)

From: Sent: To: Subject: 11/28/2012 5:28:55 PM Jeffrey Epstein [[email protected]] Re: Invite to Dialog 2014 (16 months away) Importance: High So let me understand. You are suggesting tourism? Sent from my Verizon Wireless BlackBerry From: Jeffrey Epstein <[email protected]...

Paul Desmarais Sr., 86. The Canadian billionaire, who turned an
document IMAGES-002-HOUSE_OVERSIGHT_013297.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

Paul Desmarais Sr., 86. The Canadian billionaire, who turned an inherited fleet of buses into Power Corp. of Canada, an insurance and financial services conglomerate. Died Oct. 8. Scott Carpenter, 88. The second American to orbit the Earth, he was one of the original seven astro...

and a few years of looking for God in what he called “wondering in the wilderness”
document IMAGES-002-HOUSE_OVERSIGHT_013675.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

and a few years of looking for God in what he called “wondering in the wilderness” that he began his 40 years of monastery service as cook and sandal maker. He was tt described as amazingly selfless and a “...gentle man of joyful spirit...” who “...continually walked with God.....

these diseases further from what has historically been a death sentence into a chronic, treatable
document IMAGES-007-HOUSE_OVERSIGHT_024039.txt House Oversight Committee — Epstein Estate Records (Nov 2025)

these diseases further from what has historically been a death sentence into a chronic, treatable condition. As this happens, huge markets will be created for entirely new biopharmaceutical products. While cancer is the leading disease area, this pace of dramatic scientific and t...